Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Other Long Term Assets : HK$31,947 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Other Long Term Assets?

Shanghai Fosun Pharmaceutical (Group) Co's other long-term assets for the quarter that ended in Dec. 2023 was HK$31,947 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly other long-term assets declined from Jun. 2023 (HK$31,682 Mil) to Sep. 2023 (HK$30,221 Mil) but then increased from Sep. 2023 (HK$30,221 Mil) to Dec. 2023 (HK$31,947 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual other long-term assets increased from Dec. 2021 (HK$32,757 Mil) to Dec. 2022 (HK$33,048 Mil) but then declined from Dec. 2022 (HK$33,048 Mil) to Dec. 2023 (HK$31,947 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Other Long Term Assets Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Other Long Term Assets Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

27,430.45

30,136.84

32,757.14

33,048.35

31,946.56

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															33,048.35	33,521.70	31,681.51	30,220.52	31,946.56

Shanghai Fosun Pharmaceutical (Group) Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Other Long Term Assets

Traded in Other Exchanges

SFOSF:USA 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines